PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Entries stay only in this open page and are not saved or sent.
Published record starting point
- Record display name
- Remicade
- Generic name / active ingredient
- infliximab
- Dosage-form class
- Dosage form and presentation as documented in the linked primary label
- Route
- Intravenous infusion
- Record reviewed
- 2026-08-28
Copy from the pack in hand
Source-linked reading points
- 100 mg is a product-identity clue for this single-dose vial, not an answer to vial count, saving leftovers, sharing or preparing it at home. Reconstitution, dilution, infusion, monitoring and remaining-product handling belong to the treatment facility under the current label and prescription.
- Being a TNF-related treatment, immune-modifying medicine or intravenous product does not permit self-combination, alternation or substitution with another biologic, immunosuppressant, steroid, vaccine or infection treatment.
- With fever, persistent cough, breathing trouble, severe abdominal pain, unusual bleeding, marked weakness, neurologic change or another acute concern, contact the treatment team promptly or use local urgent medical support.
Reviewed presentation examples — compare every field
- Infliximab 100 mg white lyophilised powder per single-dose vial; one vial per cartonNDC 57894-030-01